Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#7076
Rank
A$0.91 B
Marketcap
A$26.26
Share price
-0.91%
Change (1 day)
-49.00%
Change (1 year)

EPS for Avalon Pharma (Middle East Pharmaceutical) (4016.SR)

EPS in 2026 (TTM): A$0.74

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's current EPS (TTM) is A$0.76. In 2025 the company made an earnings per share (EPS) of A$1.12 an increase over its 2024 EPS that were of A$0.92.

EPS history for Avalon Pharma (Middle East Pharmaceutical) from 2023 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$0.74-33.69%
2025A$1.1221.69%
2024A$0.9221.02%
2023A$0.76